Literature DB >> 2170642

Testicular immunoregulatory factors.

P Pöllänen1, M von Euler, O Söder.   

Abstract

The present data indicate that immune cells are regulated locally in the testis by Leydig cells, Sertoli cells and resident testicular macrophages. The effects of these cells are mediated by several peptide factors, including protectin, a group of high molecular weight testicular immunosuppressive factors, and testicular interleukin-1 alpha-like factor. The testicular interleukin-1 alpha-like factor is produced by Sertoli cells and is under hypophyseal control. Its synthesis starts at puberty concomitantly with the onset of spermatogenesis and it may act as a spermatogonial growth factor. Protectin, which is under hypophyseal control, may be involved in the mechanism of prolonged transplant survival in the testicular interstitial tissue. Its levels increase at puberty. Both the testicular interleukin-1 alpha-like activity and protectin may be important in testicular pathophysiology.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170642     DOI: 10.1016/0165-0378(90)90024-z

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  4 in total

Review 1.  Role of cytokines in testicular function.

Authors:  D B Hales; T Diemer; K H Hales
Journal:  Endocrine       Date:  1999-06       Impact factor: 3.633

2.  Interleukin 1 alpha (IL1A) is a novel regulator of the blood-testis barrier in the rat.

Authors:  Oli Sarkar; Premendu P Mathur; C Yan Cheng; Dolores D Mruk
Journal:  Biol Reprod       Date:  2007-12-05       Impact factor: 4.285

3.  Infection of semen-producing organs by SIV during the acute and chronic stages of the disease.

Authors:  Anna Le Tortorec; Roger Le Grand; Hélène Denis; Anne-Pascale Satie; Karim Mannioui; Pierre Roques; Anne Maillard; Sylvanne Daniels; Bernard Jégou; Nathalie Dejucq-Rainsford
Journal:  PLoS One       Date:  2008-03-12       Impact factor: 3.240

4.  A rodent model for testicular involvement in acute lymphoblastic leukaemia.

Authors:  K Jahnukainen; I Morris; S Roe; T T Salmi; A Mäkipernaa; P Pöllänen
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.